UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

National Heart Foundation of Australia and Cardiac Society of Australia and New Zealand: Guidelines for the Prevention, Detection, and Management of Heart Failure in Australia 2018

Heart, lung & circulation, 2018-10, Vol.27 (10), p.1123-1208

2018

Volltextzugriff (PDF)

Effects of age on navigation strategy

Neurobiology of aging, 2012-01, Vol.33 (1), p.202.e15-202.e22

2012

Volltextzugriff (PDF)

Age differences in virtual environment and real world path integration

Frontiers in aging neuroscience, 2012, Vol.4, p.26-26

2012

Volltextzugriff (PDF)

Cardiovascular risk reduction in hypertension: angiotensin-converting enzyme inhibitors, angiotensin receptor blockers. Where are we up to?

Internal medicine journal, 2016-03, Vol.46 (3), p.364-372

2016

Volltextzugriff (PDF)

Eplerenone in Patients with Systolic Heart Failure and Mild Symptoms

The New England journal of medicine, 2011-01, Vol.364 (1), p.11-21

2011

Volltextzugriff (PDF)

Semaglutide in Patients with Heart Failure with Preserved Ejection Fraction and Obesity

The New England journal of medicine, 2023-09, Vol.389 (12), p.1069-1084

2023

Volltextzugriff (PDF)

Vericiguat in Patients with Heart Failure and Reduced Ejection Fraction

The New England journal of medicine, 2020-05, Vol.382 (20), p.1883-1893

2020

Volltextzugriff (PDF)

Early Responses to Intravenous Iron Therapy in Patients with Chronic Heart Failure and Iron Deficiency

Heart, lung & circulation, 2016-08, Vol.25, p.S107-S107

2016

Volltextzugriff (PDF)

Atrial shunt device for heart failure with preserved and mildly reduced ejection fraction (REDUCE LAP-HF II): a randomised, multicentre, blinded, sham-controlled trial

The Lancet (British edition), 2022-03, Vol.399 (10330), p.1130-1140

2022

Volltextzugriff (PDF)

Rivaroxaban in Patients with Heart Failure, Sinus Rhythm, and Coronary Disease

The New England journal of medicine, 2018-10, Vol.379 (14), p.1332-1342

2018

Volltextzugriff (PDF)

Effects of Serelaxin in Patients with Acute Heart Failure

The New England journal of medicine, 2019-08, Vol.381 (8), p.716-726

2019

Volltextzugriff (PDF)

Significant Reduction in All-cause Mortality with Ivabradine in Chronic Heart Failure Patients with Baseline Heart Rate ≥77 bpm: Subgroup Analysis of SHIFT

Heart, lung & circulation, 2013, Vol.22, p.S87-S88

2013

Volltextzugriff (PDF)

Chest Pain is Associated with Reduced Mortality in Acute Pulmonary Embolism

Heart, lung & circulation, 2016-08, Vol.25, p.S12-S12

2016

Volltextzugriff (PDF)

Anaemia is Associated with Increased Prevalence of Major Co-morbidities in Chronic Heart Failure

Heart, lung & circulation, 2013, Vol.22, p.S70-S71

2013

Volltextzugriff (PDF)

Heart Failure Patient Demographics and Beta-Blocker Dose in Australian Clinical Practice. An Analysis of Medicare Australia Dispensing Data

Heart, lung & circulation, 2012, Vol.21, p.S81-S82

2012

Volltextzugriff (PDF)

Iron Deficiency in Heart Failure with Relatively Preserved Left Ventricular Function is Associated with More Adverse Co-morbidities

Heart, lung & circulation, 2013, Vol.22, p.S81-S81

2013

Volltextzugriff (PDF)

Chronic Kidney Disease is a Marker of Increased Risk and Co-morbidity in Heart Failure

Heart, lung & circulation, 2013, Vol.22, p.S71-S72

2013

Volltextzugriff (PDF)

Effect of Reduced Dose Spironolactone in Heart Failure With Reduced Ejection Fraction Patients Intolerant of Full Dose Mineralocorticoid Receptor Antagonists

Heart, lung & circulation, 2024-08, Vol.33, p.S259-S259

2024

Volltextzugriff (PDF)

Effect of Seasonal Variation on Haemodynamics in Heart Failure With Reduced Ejection Fraction

Heart, lung & circulation, 2024-08, Vol.33, p.S260-S260

2024

Volltextzugriff (PDF)

Continuous home ambulatory intravenous inotropic drug therapy in severe heart failure: Safety and cost efficacy

The American heart journal, 1997-11, Vol.134 (5), p.889-900

1997

Volltextzugriff (PDF)

Is addition of angiotensin receptor blockade superior to increasing ACE inhibitor dose in patients with heart failure?

International journal of cardiology, 2010-03, Vol.139 (3), p.309-312

2010

Volltextzugriff (PDF)

Clinical Outcomes and Response to Vericiguat According to Index Heart Failure Event: Insights From the VICTORIA Trial

JAMA cardiology, 2021-06, Vol.6 (6), p.706

2021

Volltextzugriff (PDF)

Persistently Higher In-Hospital and Long-Term Mortality for Patients Admitted With Heart Failure in Regional and Remote Australia: A 20-Year Statewide Cohort Study in 154,853 Patients

Heart, lung & circulation, 2023-07, Vol.32, p.S169

2023

Volltextzugriff (PDF)

Safety and Efficacy of Oral Acetazolamide Therapy in Relief of Congestion in Patients With Heart Failure and Diuretic Resistance

Heart, lung & circulation, 2023-07, Vol.32, p.S176

2023

Volltextzugriff (PDF)

Predictors of Recovery of Left Ventricular Systolic Function in a Cohort of Patients With Cardiomyopathy Receiving the Four Pillars of Modern Heart Failure Therapy

Heart, lung & circulation, 2023-07, Vol.32, p.S171

2023

Volltextzugriff (PDF)

1 – 25 von 124

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(114)
Mit Volltextzugriff
(106)

Publikationsform

Sprache

Englisch
(121)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

National Heart Foundation of Australia and Cardiac Society of Australia and New Zealand: Guidelines for the Prevention, Detection, and Management of Heart Failure in Australia 2018

Effects of age on navigation strategy

Age differences in virtual environment and real world path integration

Cardiovascular risk reduction in hypertension: angiotensin-converting enzyme inhibitors, angiotensin receptor blockers. Where are we up to?

Eplerenone in Patients with Systolic Heart Failure and Mild Symptoms

Semaglutide in Patients with Heart Failure with Preserved Ejection Fraction and Obesity

Vericiguat in Patients with Heart Failure and Reduced Ejection Fraction

Early Responses to Intravenous Iron Therapy in Patients with Chronic Heart Failure and Iron Deficiency

Atrial shunt device for heart failure with preserved and mildly reduced ejection fraction (REDUCE LAP-HF II): a randomised, multicentre, blinded, sham-controlled trial

Rivaroxaban in Patients with Heart Failure, Sinus Rhythm, and Coronary Disease

Effects of Serelaxin in Patients with Acute Heart Failure

Significant Reduction in All-cause Mortality with Ivabradine in Chronic Heart Failure Patients with Baseline Heart Rate ≥77 bpm: Subgroup Analysis of SHIFT

Chest Pain is Associated with Reduced Mortality in Acute Pulmonary Embolism

Anaemia is Associated with Increased Prevalence of Major Co-morbidities in Chronic Heart Failure

Heart Failure Patient Demographics and Beta-Blocker Dose in Australian Clinical Practice. An Analysis of Medicare Australia Dispensing Data

Iron Deficiency in Heart Failure with Relatively Preserved Left Ventricular Function is Associated with More Adverse Co-morbidities

Chronic Kidney Disease is a Marker of Increased Risk and Co-morbidity in Heart Failure

Effect of Reduced Dose Spironolactone in Heart Failure With Reduced Ejection Fraction Patients Intolerant of Full Dose Mineralocorticoid Receptor Antagonists

Effect of Seasonal Variation on Haemodynamics in Heart Failure With Reduced Ejection Fraction

Continuous home ambulatory intravenous inotropic drug therapy in severe heart failure: Safety and cost efficacy

Is addition of angiotensin receptor blockade superior to increasing ACE inhibitor dose in patients with heart failure?

Clinical Outcomes and Response to Vericiguat According to Index Heart Failure Event: Insights From the VICTORIA Trial

Persistently Higher In-Hospital and Long-Term Mortality for Patients Admitted With Heart Failure in Regional and Remote Australia: A 20-Year Statewide Cohort Study in 154,853 Patients

Safety and Efficacy of Oral Acetazolamide Therapy in Relief of Congestion in Patients With Heart Failure and Diuretic Resistance

Predictors of Recovery of Left Ventricular Systolic Function in a Cohort of Patients With Cardiomyopathy Receiving the Four Pillars of Modern Heart Failure Therapy

Suchergebnisse filtern